Trials had found no significant benefit from the use of plasmaThe use of convalescent plasma has been dropped from the recommended treatment guidelines for COVID-19, according to late Monday advisory from the Indian Council of Medical Research (ICMR). The National Task Force of the ICMR, along with experts from the Health Ministry, periodically updates guidelines on recommended modes of treatment. Several other international trials had also found no benefit from plasma therapy. Explained | What is convalescent plasma therapy? The ICMR guidelines continue to recommend Ivermerctin and hydroxychloroquine for mild disease but has also underlined that both drugs had “low certainty of evidence”.

Source: The Hindu May 17, 2021 17:33 UTC